Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

Sieghart Sopper; Satu Mustjoki; Deborah White; Timothy Hughes; Peter Valent; Andreas Burchert; Bjorn T. Gjertsen; Guenther Gastl; Matthias Baldauf; Zlatko Trajanoski; Frank Giles; Andreas Hochhaus; Thomas Ernst; Thomas Schenk; Jeroen J. W. M. Janssen; Gert J. Ossenkoppele; Kimmo Porkka; Dominik Wolf

doi:https://doi.org/10.1200/JCO.2016.67.0893

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

Sieghart Sopper, Satu Mustjoki, Deborah White, Timothy Hughes, Peter Valent, Andreas Burchert, Bjorn T. Gjertsen, Guenther Gastl, Matthias Baldauf, Zlatko Trajanoski, Frank Giles, Andreas Hochhaus, Thomas Ernst, Thomas Schenk, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Kimmo Porkka, Dominik Wolf

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	English
Pages (from-to)	175-+
Journal	Journal of clinical oncology
Volume	35
Issue number	2
DOIs	https://doi.org/10.1200/JCO.2016.67.0893
Publication status	Published - 10 Jan 2017

Access to Document

https://doi.org/10.1200/JCO.2016.67.0893

Cite this

Sopper, S., Mustjoki, S., White, D., Hughes, T., Valent, P., Burchert, A., Gjertsen, B. T., Gastl, G., Baldauf, M., Trajanoski, Z., Giles, F., Hochhaus, A., Ernst, T., Schenk, T., Janssen, J. J. W. M., Ossenkoppele, G. J., Porkka, K., & Wolf, D. (2017). Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia. Journal of clinical oncology, 35(2), 175-+. https://doi.org/10.1200/JCO.2016.67.0893

@article{df7da29aae30488c8c60bb2cd55837b7,

title = "Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia",

author = "Sieghart Sopper and Satu Mustjoki and Deborah White and Timothy Hughes and Peter Valent and Andreas Burchert and Gjertsen, {Bjorn T.} and Guenther Gastl and Matthias Baldauf and Zlatko Trajanoski and Frank Giles and Andreas Hochhaus and Thomas Ernst and Thomas Schenk and Janssen, {Jeroen J. W. M.} and Ossenkoppele, {Gert J.} and Kimmo Porkka and Dominik Wolf",

year = "2017",

month = jan,

day = "10",

doi = "https://doi.org/10.1200/JCO.2016.67.0893",

language = "English",

volume = "35",

pages = "175--+",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

Sopper, S, Mustjoki, S, White, D, Hughes, T, Valent, P, Burchert, A, Gjertsen, BT, Gastl, G, Baldauf, M, Trajanoski, Z, Giles, F, Hochhaus, A, Ernst, T, Schenk, T, Janssen, JJWM , Ossenkoppele, GJ, Porkka, K & Wolf, D 2017, 'Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia', Journal of clinical oncology, vol. 35, no. 2, pp. 175-+. https://doi.org/10.1200/JCO.2016.67.0893

Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia. / Sopper, Sieghart; Mustjoki, Satu; White, Deborah et al.
In: Journal of clinical oncology, Vol. 35, No. 2, 10.01.2017, p. 175-+.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous Leukemia

AU - Sopper, Sieghart

AU - Mustjoki, Satu

AU - White, Deborah

AU - Hughes, Timothy

AU - Valent, Peter

AU - Burchert, Andreas

AU - Gjertsen, Bjorn T.

AU - Gastl, Guenther

AU - Baldauf, Matthias

AU - Trajanoski, Zlatko

AU - Giles, Frank

AU - Hochhaus, Andreas

AU - Ernst, Thomas

AU - Schenk, Thomas

AU - Janssen, Jeroen J. W. M.

AU - Ossenkoppele, Gert J.

AU - Porkka, Kimmo

AU - Wolf, Dominik

PY - 2017/1/10

Y1 - 2017/1/10

U2 - https://doi.org/10.1200/JCO.2016.67.0893

DO - https://doi.org/10.1200/JCO.2016.67.0893

M3 - Article

C2 - 28056193

SN - 0732-183X

VL - 35

SP - 175-+

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 2

ER -